Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Talkpool consolidates its IoT companies Talkpool AB and Home Solutions

The shareholders in Talkpool AB have agreed to accept an offer from Nordic Proptech Investment Services AB/Home Solutions (NPTIS) to acquire 100% of the shares in Talkpool AB. The shares will be paid with newly emitted NPTIS shares. Talkpool AG, the mother company of the international technology group Talkpool and majority owner of both Talkpool AB and NPTIS, will hold 51,9% of the new Swedish IoT company specialized in Smart Buildings. 48,1% will be held by Talkpool’s current co-owner Sacculus, together with the existing shareholders in Talkpool AB. Talkpool AB contributes with

QUARTERLY REPORT, THIRD QUARTER 2021

    Press release: Stockholm, October 15, 2021, 08.45 CET HIGHLIGHTS OF THE THIRD QUARTER 2021 · Net sales was 83 MSEK (130) · EBITDA was 13 MSEK (58) · EBIT was -9 MSEK (40) · Earnings per share was -0,07 SEK (0.18) · Operative cashflow in Q3 was 14 (22) MSEK and cash and cash equivalents were 48 MSEK (30) · Investments were 10 MSEK (4) · The production was about 308 000 (433 000) ounces silver, 839 (923) ounces gold, 323 (419) tonnes lead, and 742 (818) tonnes zinc in concentrates · Costs, i.e., supplies and other expenses, were 59 MSEK which was

BioStock: Chordate Medical’s CEO on US marketing plans

Chordate Medical is initiating a pre-study in the US as a first step in obtaining market authorisation from the FDA for its migraine treatment. The pre-study is expected to be completed in Q1 2021 and will provide clarity as to which pathway is appropriate to achieve market approval in the US. BioStock contacted CEO Anders Weilandt to learn more about the process leading up to FDA approval and the possibilities in the US for the company’s migraine treatment.Read the full interview with CEO Anders Weilandt at biostock.se: https://www.biostock.se/en/2021/10/chordate-medicals-ceo-on-us-

Ford Honors Veoneer at 23rd Annual World Excellence Awards

· Veoneer has been honored by Ford Motor Company with a Create Must-Have Products World Excellence Award · Ford’s World Excellence Awards recognize companies that exceed expectations and achieve the highest levels of excellence in quality, cost, performance and delivery · Award categories include Treat Customers Like Family, Turn Around Automotive Operations and Compete Like a Challenger, Create Must-Have Products, Sustainability, Diversity and Inclusion, plus Gold and Silver Quality awards Stockholm, Sweden, October 15, 2021: The automotive technology company Veoneer, Inc. (

Epiroc wins large equipment order for greenfield mine in Canada

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, has won a large order for surface mining equipment from IAMGOLD Corp. in Canada that will optimize safety and productivity through advanced automation. The machines will be used in production at a greenfield gold mine currently under construction.IAMGOLD has ordered several Pit Viper 231 and SmartROC D65 drill rigs for use at Côté Gold in Ontario, Canada, an open pit gold mine that is currently under construction and expected to start production in the second half of

Implantica announces initial UK surgical training for RefluxStop™

Implantica AG (publ) today announces that surgeons from three prominent reflux centers in the UK have completed RefluxStop™ training.“We are pleased to move forward in the UK after an extended break due to COVID-19. UK is an important market for RefluxStop™ where the device is reimbursed also in public healthcare (NHS). There are more than 4.6 million daily acid reflux sufferers in the UK, with around 400’000 patients annually diagnosed with acid reflux after staying overnight at a hospital and performing a diagnostic endoscopic procedure. We look forward to commencing surgeries in the near-

IRRAS Accounces Participation and Data Presentations at Two Upcoming, In-Person Neurosurgery Conferences

Stockholm, October 15, 2021 - IRRAS, a global medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that it will be participating in-person at the Congress of Neurological Surgeons’ annual meeting (CNS 2021), in Austin, TX, on October 16-20, 2021, as well as the Neurocritical Care Society’s annual meeting (NCS 2021), in Chicago, IL, on October 26-29, 2021. In addition, at CNS 2021, clinical data regarding the use of its IRRAflow system in the treatment of intracerebral hemorrhage (ICH) and intraventricular hemorrhage (IVH)

Invitation to presentation of Bravida’s sustainability strategy

Bravida's sustainability strategy will be presented by President and CEO Mattias Johansson at 10.30 on 26 October 2021.The presentation will be held in English and can be followed on the web or on the phone. There will be room for questions in the telephone conference. Link to webcasthttps://tv.streamfabriken.com/bravida-q3-2021Telephone conference dial-in numberSE:  +46856642704 (Lokalt tel.nr) UK:  +443333009263 (Lokalt tel.nr)US:  +1 6319131422 (Lokalt tel.nr PIN: 1345 1744#) The presentation will be available on www.bravida.se/en/investorsFor further information,

BEWI – Shareholders representing the remaining 50 per cent of shares in Jackon accept the offer

With reference to the stock exchange notice issued by BEWI ASA ("BEWI" or the "Company") on 1 October 2021 regarding its offer to acquire all shares in Jackon Holding ("Jackon") and the announcement on 3 October 2021 regarding the acceptance received for 50 per cent of the shares in Jackon, BEWI now announces that the Company has received acceptances of the offer from shareholders holding the remaining 50 per cent of the shares in Jackon. All shareholders in Jackon have accordingly accepted the offer and share purchase agreements have been entered into between the parties. The Jackon

New US patent approval for Episurf Medical

Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled “Determination and visualization of damage to an anatomical joint”, relates to 3D-based assessment of joint lesions, and complements Episurf Medical’s earlier US patents within this field. “With this we get additional IP protection in the US within the important and exciting field of medical imaging and surgical pre-planning. This constitutes an essential part of the company’s Episealer® implant technology” comments Katarina Flodström,

BioStock: Respiratorius begins production of VAL001

Respiratorius’ two development projects are running at full speed and a new formulation has been developed for the candidate VAL001. This paves the way for the next step and the company is now starting production for a phase I pharmacokinetic study with the new formulation. BioStock contacted the company’s CEO Johan Drott to find out more.Read the full article at biostock.se:https://www.biostock.se/en/2021/10/respiratorius-begins-production-of-val001/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Imfinzi & tremelimumab improved OS in liver cancer

15 October 2021 7:00 BST Imfinzi plus tremelimumab significantly improved overall survival in HIMALAYA Phase III trial in 1st-line unresectable liver cancer Trial met primary endpoint of overall survival with a single priming dose of tremelimumab plus Imfinzi every four weeks vs. sorafenib Imfinzi monotherapy met the overall survival endpoint of non-inferiority vs. sorafenib Positive high-level results from the HIMALAYA Phase III trial showed a single, high priming dose of tremelimumab added to Imfinzi (durvalumab) demonstrated a statistically significant and clinically

Invitation to conference call with web presentation of AcadeMedia's quarterly report for July - September 2021/22

AcadeMedia's quarterly report for July - September 2021/22 will be published at 08:00 CEST on 29 October. A web-cast telephone conference will be held at 09:30 CEST the same day, where CEO Marcus Strömberg and CFO Katarina Wilson will present the report. The presentation will be held in English and can be followed on the web or over the phone. It will be followed by a Q&A session. To participate in the conference call, and thereby be able to ask questions, call one of the following numbers ten minutes before the start of the call:SE: +46 8 5055 8374UK: +44 33 3300 9030US: +1 646

Invitation to conference call with web presentation of Cloetta AB´s interim report Q3 2021

Cloetta AB will publish the interim report for the period 1 July – 30 September 2021 on Friday 29 October 2021 at 08.00 a.m. CEST. Following this report Cloetta will organize a conference call with web presentation for media and the financial community.President and CEO Henri de Sauvage Nolting and CFO Frans Rydén will present and comment on the report. After the presentation there will be time for questions, both on the phone and in the web presentation. Time for the publication of the interim reportFriday 29 October at 08:00 a.m. CEST  Time for conference call and web presentation

Metso Outotec to deliver modular cobalt solvent extraction technology to Canada

Metso Outotec Corporation’s press release on October 15, 2021, at 09:00 a.m. EESTMetso Outotec has signed an agreement with the Canadian battery materials company First Cobalt Corporation to deliver Planet Positive  solvent extraction technology to their cobalt refinery expansion in Ontario. The value of the order is approximately EUR 10 million, and it has been booked into Metals’ Q4/2021 orders received. Metso Outotec’s scope of delivery includes the engineering and supply of a modular VSF®X solvent extraction

Nomination Committee appointed ahead of Collector’s AGM 2022

Collector AB (publ)’s Annual General Meeting will be held on Wednesday 4 May 2022. It is hereby announced that the company’s largest shareholders have appointed a Nomination Committee.The Nomination Committee has, ahead of the Annual General Meeting 2022, the following composition: · Sharam Rahi, appointed by Fastighets AB Balder, · Anna-Maria Lundström, appointed by StrategiQ Capital AB, · Jesper Mårtensson, appointed by Förvaltnings AB Färgax, and · Erik Selin, Chairman of the Board of Collector AB (publ) Sharam Rahi has been appointed Chairman of the Nomination Committee.

OKEA third quarter 2021 trading update

Oslo, 15 October 2021) OKEA ASA (OKEA: OSE: OKEA) today announces a trading update for the third quarter of 2021 with a production of 16 315 barrels of oil equivalents per day (boepd), compared to 13 210 boepd in the previous quarter, and an operating income of NOK 1 026 (607) million.“OKEA continues to deliver solid operational results and recorded a three-fold growth in revenues in the third quarter compared to last year, backed by strong oil and gas prices. We are on track to start production at Yme shortly, which will further strengthen OKEA's production and cash flow, providing a

Lime Technologies AB's (publ) Nomination Committee for the 2022 Annual General Meeting

In accordance with the decision by Lime Technologies' Annual General Meeting on April 27, 2021, the Chairman of the Board, Martin Henricsson, has summoned the Nomination Committee. After consultation with the major shareholders of the company as per August 31, 2021, the Committee consists of the following members: · Emil Hjalmarsson, Chairman of the Nomination Committee, representing Grenspecialisten AB and 10.0 % of the shares and votes · Veronica Sandman, representing Syringa Capital AB (owned by Erik Syrén) and 10.1 % of the shares and votes · Jan Dworsky, representing

Vestas to install V236-15.0 MW prototype turbine at Østerild in Denmark

News release from Vestas Wind Systems A/SAarhus, 15 October 2021 Vestas has decided to install the V236-15 MW offshore prototype wind turbine at the Østerild National test centre for large wind turbines in Western Jutland, Denmark. The installation of the prototype turbine will take place in the second half of 2022 and its first kWh is planned for the fourth quarter of that year. Stretching 280m into the air with a production output of 80 GWh/year, the prototype will be the tallest and most powerful wind turbine in the world once installed. Anders Nielsen, Vestas Chief Technology

SBB is growing in Höganäs with 80 new build apartments

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) is building 80 apartments in the Sjöcrona area in Höganäs. The houses are built in a factory with a solid wooden frame and with half the energy use of the requirements in BBR. SBB continues to grow in Höganäs with new build energy-efficient 1-3 room apartments. Through an efficient industrial construction method, the houses are built with solid wood frames and the majority of the houses are built in a factory to be assembled on site. With this method, SBB reduces construction costs and construction time with a large sustainability gain

Stora Enso shares converted

STORA ENSO OYJ STOCK EXCHANGE RELEASE 15 October 2021 at 9.00 EESTDuring the 1 September 2021 – 30 September 2021 conversion period there were two conversions and a total of 510 A shares were converted into R shares. The shares were recorded in the Finnish trade register today, 15 October 2021, and trading in the new R shares will start on 18 October 2021.Breakdown of shares after conversion:  A shares 176 248 123R shares 612 371 864Total 788 619 987 Each A share and each ten R shares carry one vote. The total amount of votes after the conversion is at least 237 485 309.

YIT’s co-operation negotiations have concluded in Finland

YIT Corporation Investor news 15 October 2021 at 9:00 a.m.YIT has concluded the co-operation negotiations concerning white collar employees in Finland. The co-operation negotiations covered the transition to a more efficient, competitive, and customer-oriented operating model, as well as the implications on personnel and options related to the planned change. The organisational changes to operate according to the new operating model have now started and they will be effective as of 1 January 2022. The estimated number of personnel to be reduced is at the maximum of 230 employees in the

Alelion strengthens sales team after a very strong intake of orders

Alelion Energy Systems' order intake has increased sixfold during the first half of 2021, compared with the same period last year. Alelion therefore strengthens its sales team with Pontus Grimberg, who has many years of experience in sales and brand building in the international market.Manufacturers of special and heavy-duty vehicles show an increasing interest in Alelion's advanced high-voltage battery systems to reduce the climate footprint of operations in ports, airports, contracting and logistics. - In line with the increasing demand, Alelion needs to further strengthen its sales

Nordisk Bergteknik announces that the conditions for the early redemption of outstanding corporate bonds have been fulfilled

Nordisk Bergteknik AB (publ) (”Nordisk Bergteknik” or the ”Company”) will redeem all outstanding corporate bonds of SEK 400 million, 2019/2023 with ISIN SE0012729234 (the “Bonds”) pursuant the terms and conditions of the Bonds. In accordance with the press release dated 27 September 2021 have all conditions for the redemption of the Bonds been fulfilled, among other things have Nordisk Bergteknik listed the Company’s B-shares on Nasdaq Stockholm and obtained share issue proceeds of at least SEK 450 million. Nordisk Bergteknik will therefore redeem all outstanding Bonds. The date for

There are no items matching the current filter
There are no more items matching the current filter
Back to top